Results 1 to 10 of about 4,331 (136)

Coronary artery disease in a patient with Addison’s disease: a case report and literature review [PDF]

open access: yesBMC Cardiovascular Disorders, 2023
Background Addison’s disease which is due to dysfunction of the adrenal gland, with abnormal secretion of glucocorticoids and mineralocorticoids, is rare.
Ruohan Zhao   +4 more
doaj   +2 more sources

Unmasking of Addison’s disease in COVID-19 [PDF]

open access: yesSAGE Open Medical Case Reports, 2021
This case report highlights the initial presentation of Addison’s disease in a 19-year-old individual with coronavirus disease. Coronavirus disease is an infectious disease, which often presents with fever and respiratory and gastrointestinal symptoms ...
Pallav Bhattarai   +4 more
doaj   +2 more sources

Familial associations for Addison’s disease and between Addison’s disease and other autoimmune diseases [PDF]

open access: yesEndocrine Connections, 2020
Design: Addison’s disease (AD) is a rare autoimmune disease (AID) of the adrenal cortex, present as an isolated AD or part of autoimmune polyendocrine syndromes (APSs) 1 and 2.
Hauke Thomsen   +5 more
doaj   +2 more sources

Cardiac Tamponade in Adrenoleukodystrophy with Addison’s Disease [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
Cardiac tamponade is a life-threatening medical emergency and can arise in many clinical situations. We present the case of a 59-year-old man with adrenoleukodystrophy and Addison’s disease who was admitted to the emergency department with severe ...
Mafalda Sá Pereira   +2 more
doaj   +2 more sources

Cardiac Tamponade as the Initial Presentation of Coexistent Systemic Lupus Erythematosus and Addison’s Disease: A Case Report and Literature Review [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports
Cardiac tamponade is a rare presentation of systemic lupus erythematosus (SLE), occurring in less than 1% of cases. Its coexistence with primary adrenal insufficiency (Addison’s disease) represents an even rarer clinical scenario.
Abdullah Abu Keshek MD   +5 more
doaj   +2 more sources

Addison’s disease associated with hypokalemia: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2021
Background Primary adrenal insufficiency (Addison's disease) is a rare medical condition usually associated with hyperkalemia or normokalemia. We report a rare case of Addison's disease, coexisting with hypokalemia, requiring treatment. Case presentation
M. Abdalla, J. A. Dave, I. L. Ross
doaj   +2 more sources

Conceptualising quality early childhood education: Learning from young children in Brazil and South Africa through creative and play‐based methods

open access: yesBritish Educational Research Journal, EarlyView., 2023
Abstract Early childhood has increasingly been acknowledged as a vital time for all children. Inclusive and quality education is part of the United Nations Sustainable Development Goals, with the further specification that all children have access to quality pre‐primary education.
Laura H. V. Wright   +8 more
wiley   +1 more source

Reversible cerebellar ataxia and bipolar disorder secondary to tuberculous adrenalitis

open access: yesInternational Journal of Mycobacteriology, 2021
Addison's disease is primary adrenal insufficiency which is most commonly due to an autoimmune disease. Patients usually presents with fatigue, anorexia, gastrointestinal complaints, salt craving, and orthostatic hypotension.
Mansoor C Abdulla
doaj   +1 more source

Addison’s Disease Mimicking as Acute Pancreatitis: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Over past two decades there has been significant improvement in medical field in elucidating the underlying pathophysiology and genetics of Addison’s disease.
Sayani Chaudhuri   +4 more
doaj   +1 more source

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

open access: yesHepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy